Research Article
Hypercoordinated Organosilicon(IV) and Organotin(IV) Complexes: Syntheses, Spectral Studies, and Antimicrobial Activity In Vitro
Table 3
13C NMR chemical shifts of the ligands and their metal complexes.
| Compound | C1/C2 | C3/C4 | C5/C6 | C7/C8 | C9/C10 | C11/C12 | M–CH3 |
| HL1 | 123.18/127.64 | 130.46/130.87 | 135.12/134.75 | 162.36/153.96 | 158.47/10.29 | 18.90 | — | Me2SiCl(L1) | 122.06/128.04 | 130.68/130.96 | 136.93/135.42 | 166.84/147.99 | 154.43/20.19 | 12.78 | 31.43 | Me2Si(L1)2 | 121.93/127.05 | 130.72/130.81 | 136.26/133.92 | 167.25/147.09 | 153.23/21.81 | 12.05 | 29.34 | Me2SnCl(L1) | 122.27/127.32 | 129.92/131.03 | 136.43/133.98 | 165.23/149.06 | 153.92/19.53 | 12.89 | 33.89 | Me2Sn(L1)2 | 122.67/127.08 | 130.77/130.97 | 136.39/134.41 | 164.89/149.48 | 153.54/18.97 | 14.44 | 31.54 | HL2 | 123.18/127.58 | 130.47/130.93 | 135.13/134.75 | 162.38/152.88 | 158.50/13.62 | 19.47/26.97 | — | Me2SiCl(L2) | 122.94/127.43 | 129.78/131.25 | 136.78/134.17 | 163.79/151.56 | 154.26/22.12 | 15.65/22.14 | 30.45 | Me2Si(L2)2 | 122.71/127.49 | 131.75/131.13 | 136.91/135.54 | 164.21/150.97 | 155.03/19.96 | 24.97/18.58 | 33.86 | Me2SnCl(L2) | 123.69/127.39 | 130.98/131.06 | 136.79/134.23 | 164.02/151.39 | 154.89/23.53 | 19.06/19.36 | 32.42 | Me2Sn(L1)2 | 121.91/127.26 | 130.74/130.74 | 137.13/134.72 | 163.89/152.03 | 154.38/21.26 | 23.02/14.77 | 34.53 |
| |
|
|